Skip to content

Measuring Integrated Novel Dimensions in Neurodevelopmental and Stress-related Mental Disorders

Measuring Integrated Novel Dimensions in Neurodevelopmental and Stress-related Mental Disorders - MIND-Set

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON50325
Enrollment
650
Registered
2016-02-10
Start date
2016-04-11
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychiatric diseases Psychiatric disorders

Interventions

None listed

Sponsors

Psychiatrie
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients: - Adult (age>17) in- and outpatients at the Department of Psychiatry of the Radboudumc - with a neurodevelopmental disorder: Autism Spectrum Disorder and/ or Attention-Deficit/ Hyperactivity Disorder - and/ or a stress-related disorder: mood disorder, addiction disorder, mood disorders with somatic comorbidity.Healthy controls: - Adult (age >17) individuals - without a lifetime history of psychiatric disorders.

Exclusion criteria

Exclusion criteria: Patients: - Full scale IQ estimate

Design outcomes

Primary

MeasureTime frame
Socio-demographics Descriptive psychopathology, somatic status and treatment history Biological measures, such as cortisol levels Neuropsychology Genetics Gut microbiome Neuroimaging

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)